High materiality7/10
Definium Therapeutics price target raised to $70 from $60 at Oppenheimer
Why it may matterVerify against the original reporting
Strong bullish setup
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Oppenheimer raises DFTX price target to $70; current price $43.05.
- Oppenheimer raises price target to $70; current price is $43.05.
Key facts
- 01
Target: $70
- 02
Posted price: $43.05
- 03
Analyst firm: Oppenheimer
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.